InMed Pharmaceuticals Inc. cotiza a 1.34 USD y tiene una capitalización bursátil de $7M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabin…
| Periodo | 2026-11 | 2022-11 | 2022-09 | 2022-05 |
|---|---|---|---|---|
| Real | — | $-107.86 | $-118.83 | $-161.65 |
| Estimado | — | $-108.50 | $-142.50 | $-159.50 |
| Sorpresa | — | +0.6% | +16.6% | -1.3% |
| Métrica | INM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -1168.4% | -40.4% | -1128.0% |
| ROA | -414.5% | -32.0% | -382.5% |
| Current Ratio | 1.37 | 2.84 | -1.47 |
| Debt / Equity | — | 0.28 | — |